SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012202
Filing Date
2019-08-13
Accepted
2019-08-13 16:06:32
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 329415
2 ex31-1.htm EX-31.1 38960
3 ex32-1.htm EX-32.1 13404
  Complete submission text file 0001493152-19-012202.txt   2222028

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE vbio-20190630.xml EX-101.INS 321092
5 XBRL SCHEMA FILE vbio-20190630.xsd EX-101.SCH 36836
6 XBRL CALCULATION FILE vbio-20190630_cal.xml EX-101.CAL 40604
7 XBRL DEFINITION FILE vbio-20190630_def.xml EX-101.DEF 83382
8 XBRL LABEL FILE vbio-20190630_lab.xml EX-101.LAB 239482
9 XBRL PRESENTATION FILE vbio-20190630_pre.xml EX-101.PRE 171106
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53832 | Film No.: 191020667
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services